Jozica Johanna Kutin

Jozica Johanna Kutin

Auto-generated profile, based on publicly available information

Jozica Johanna Kutin

School of Economics, Finance and Marketing, RMIT University , Melbourne, VIC , Australia

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 1995 in The Lancet
Verified
Journal Article
Closed access
LHL van Herwerden
L van Herwerden
SHS.B Harrap
S.B Harrap
ZWZ.Y.H Wong
Z.Y.H Wong
Michael AbramsonMichael Abramson
Michael Abramson
JKJ.J Kutin
J.J Kutin
EWE.H Walters
E.H Walters

1 June 2017 in Australian and New Zealand Journal of Public Health
Verified
Journal Article
Open access
PDF file
JKJozica Kutin
Jozica Kutin
RRRoslyn Russell
Roslyn Russell
MRMike Reid
Mike Reid
Objective: Economic abuse is a form of domestic violence that has a significant impact on the health and financial wellbeing of victims, but is understudied. This study determined the lifetime prevalence of economic abuse in Australia by age and gender, and the associated risk factors. Methods: The 2012 ABS Personal Safety Survey was used, involving a cross-sectional population survey of 17,050 randomly selected adults using face-to-face interviews. The survey-weighted prevalence of economic abuse was calculated and analysed by age and gender. Logistic regression was used to adjust odds ratios for possible confounding between variables. Results: The lifetime prevalence of economic abuse in the whole sample was 11.5%. Women in all age groups were more likely to experience economic abuse (15.7%) compared to men (7.1%). Disability, health and financial stress status were significant markers of economic abuse. Conclusions: For women, financial stress and disability were important markers of economic abuse. However, prevalence rates were influenced by the measures used and victims' awareness of the abuse, which presents a challenge for screening and monitoring. Implications for public health: Social, health and financial services need to be aware of and screen for the warning signs of this largely hidden form of domestic violence.

6 May 2004 in The American Journal on Addictions
Verified
Journal Article
Closed access
PDF file
NLNicholas Lintzeris
Nicholas Lintzeris
ARAlison Ritter
Alison Ritter
MPMary Panjari
Mary Panjari
NCNicolas Clark
Nicolas Clark
JKJozica Kutin
Jozica Kutin
GBGabriele Bammer
Gabriele Bammer
Buprenorphine was registered in Australia as a maintenance and detoxification agent for the management of opioid dependence in November, 2000, and became widely available in August, 2001. This paper provides an overview of key developments in the introduction of buprenorphine treatment in Australia, with an emphasis upon the delivery of services in community‐based (primary care) settings. A central study in this work was the Buprenorphine Implementation Trial (BIT), a randomized, controlled trial comparing buprenorphine and methadone maintenance treatment delivered under naturalistic conditions by specialist and community‐based service providers (general practitioners and community pharmacists) in 139 subjects across nineteen treatment sites. In addition to conventional patient outcome measures (treatment retention, drug use, psychosocial functioning, and cost effectiveness), the BIT study also involved the development and evaluation of clinical guidelines, training programs for clinicians, and client literature, which are described here. Integration of treatment systems (methadone with buprenorphine, specialist and primary care programs) and factors thought to be important in the uptake of buprenorphine treatment in Australia since registration are discussed.

1 December 1996 in Respirology
Verified
Journal Article
Closed access
PDF file
Michael AbramsonMichael Abramson
Michael Abramson
JKJozica J Kutin
Jozica J Kutin
JRJoan Raven
Joan Raven
ALAnna Lanigan
Anna Lanigan
DCDaniel Czarny
Daniel Czarny
EWE Haydn Walters
E Haydn Walters

1 August 1992 in Australian and New Zealand Journal of Medicine
Verified
Journal Article
Closed access
PDF file
Michael AbramsonMichael Abramson
Michael Abramson
JKJ. Kutin
J. Kutin
GBG. Bowes
G. Bowes

1 January 1994 in Clinical Pharmacology & Therapeutics
Verified
Journal Article
Closed access
PDF file
SGSteven Gourlay
Steven Gourlay
AFAndrew Forbes
Andrew Forbes
TMTracey Marriner
Tracey Marriner
JKJozica Kutin
Jozica Kutin
JMJohn McNeil
John McNeil